Kendra Adams

Insider Reports History

Entity
Individual
Location
C4 Therapeutics, Inc., 490 Arsenal Way, Suite 120, Watertown, MA
Signature
/s/ Jolie M. Siegel, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kendra Adams:

Stock Role Class Num Shares Value Price $ Report Date Ownership
C4 Therapeutics, Inc. Chief Financial Officer Common Stock 84.4K $510K $6.04 Nov 7, 2024 Direct
C4 Therapeutics, Inc. Chief Financial Officer Performance Restricted Stock Units 10.5K $63.4K $6.04 Nov 7, 2024 Direct
C4 Therapeutics, Inc. Chief Financial Officer Stock Option (Right to Buy) 45K Mar 7, 2024 Direct

Insider Reports Filed by Kendra Adams

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CCCC C4 Therapeutics, Inc. Nov 7, 2024 3 -$6.66K 4 Nov 12, 2024 Chief Financial Officer
CCCC C4 Therapeutics, Inc. Sep 18, 2024 1 -$11.7K 4 Sep 20, 2024 Chief Financial Officer
CCCC C4 Therapeutics, Inc. Sep 16, 2024 3 -$4.2K 4 Sep 17, 2024 Chief Financial Officer
CCCC C4 Therapeutics, Inc. Mar 7, 2024 2 $0 4 Mar 8, 2024 Chief Financial Officer
CCCC C4 Therapeutics, Inc. Feb 13, 2024 3 -$8.5K 4 Feb 15, 2024 Chief Financial Officer
CCCC C4 Therapeutics, Inc. Sep 18, 2023 2 $0 4 Sep 19, 2023 Chief Financial Officer
CCCC C4 Therapeutics, Inc. Sep 18, 2023 0 $0 3 Sep 19, 2023 Chief Financial Officer